BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23937507)

  • 21. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.
    Soyka M; Winter C; Kagerer S; Brunnauer M; Laux G; Möller HJ
    J Psychiatr Res; 2005 Jan; 39(1):101-8. PubMed ID: 15504428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged delirium managed with risperidone.
    Bourgeois JA; Hilty DM
    Psychosomatics; 2005; 46(1):90-1. PubMed ID: 15765831
    [No Abstract]   [Full Text] [Related]  

  • 24. Association between risperidone treatment and cerebrovascular adverse events in elderly patients with dementia.
    Formiga F; Fort I; Pérez-Castejón JM; Ruiz D; Duaso E; Riu S
    J Am Geriatr Soc; 2005 Aug; 53(8):1446-8. PubMed ID: 16078986
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
    Fang M; Chen H; Li LH; Wu R; Li Y; Liu L; Ye M; Huang J; Zhu S; Wang G; Zhang Q; Zheng H; Zhang L; Wang B; Zhou J; Zhao JP
    Int Clin Psychopharmacol; 2012 Mar; 27(2):107-13. PubMed ID: 22233697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
    Csernansky JG; Mahmoud R; Brenner R;
    N Engl J Med; 2002 Jan; 346(1):16-22. PubMed ID: 11777998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
    Kane JM; Potkin SG; Daniel DG; Buckley PF
    J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuroleptic malignant syndrome in users of risperidone].
    Vorel SK; Bos F; Vorel-Havelkova E; Brombacher PJ
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):159-60; author reply 160. PubMed ID: 15693596
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
    Ouyang WC; Hsu MC; Yeh IN; Kuo CC
    Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QTc prolongation: possible association with risperidone and/or haloperidol.
    Nandagopal JJ; Craig JM; Lippmann S
    Psychosomatics; 2003; 44(6):521. PubMed ID: 14597690
    [No Abstract]   [Full Text] [Related]  

  • 32. The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission, and Death in Dementia Patients.
    Nerius M; Johnell K; Garcia-Ptacek S; Eriksdotter M; Haenisch B; Doblhammer G
    J Gerontol A Biol Sci Med Sci; 2018 Sep; 73(10):1396-1402. PubMed ID: 29228107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
    McSwain ML; Forman LM
    J Clin Psychopharmacol; 1995 Aug; 15(4):284. PubMed ID: 7593712
    [No Abstract]   [Full Text] [Related]  

  • 34. Sleep-related eating disorder induced by risperidone.
    Lu ML; Shen WW
    J Clin Psychiatry; 2004 Feb; 65(2):273-4. PubMed ID: 15003084
    [No Abstract]   [Full Text] [Related]  

  • 35. Antipsychotic drugs for aggression in intellectual disability.
    Matson JL; Wilkins J
    Lancet; 2008 Jan; 371(9606):9-10. PubMed ID: 18177758
    [No Abstract]   [Full Text] [Related]  

  • 36. Risperidone-induced leucopenia and neutropenia: a case report.
    Sluys M; Güzelcan Y; Casteelen G; de Haan L
    Eur Psychiatry; 2004 Apr; 19(2):117. PubMed ID: 15051112
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse interaction of tacrine and haloperidol.
    Maany I
    Am J Psychiatry; 1996 Nov; 153(11):1504. PubMed ID: 8890692
    [No Abstract]   [Full Text] [Related]  

  • 38. CSM warning on atypical psychotics and stroke may be detrimental for dementia.
    Mowat D; Fowlie D; MacEwan T
    BMJ; 2004 May; 328(7450):1262. PubMed ID: 15155521
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hypothermia due to antipsychotic drug: A case report].
    Arditti R; Mongin Y; Drancourt N; Hotier S; Laguerre A; Hamdani N
    Encephale; 2020 Jun; 46(3):222-223. PubMed ID: 32151448
    [No Abstract]   [Full Text] [Related]  

  • 40. Multifocal myoclonus induced by haloperidol.
    Domínguez C; Benito-León J; Bermejo-Pareja F
    Neurol Sci; 2009 Oct; 30(5):385-6. PubMed ID: 19526195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.